Journal
CLEVELAND CLINIC JOURNAL OF MEDICINE
Volume 84, Issue 6, Pages 463-470Publisher
CLEVELAND CLINIC
DOI: 10.3949/ccjm.84a.15140
Keywords
-
Categories
Ask authors/readers for more resources
Estrogen receptor agonist-antagonists (ERAAs) selectively inhibit or stimulate estrogen-like action in targeted tissues. This review summarizes how ERAAs can be used in combination with an estrogen or alone to treat menopausal symptoms (vasomotor symptoms, genitourinary syndrome of menopause), breast cancer or the risk of breast cancer, osteopenia, osteoporosis, and other female midlife concerns.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available